Psychiatry Drug Alerts
Psychiatry Drug Alerts is an 8-page monthly update on the efficacy and safety of psychiatric drugs. The ALERTS in Psychiatry Drug Alerts are summaries, from a variety of journals, that can help you solve a problem, warn you about safety, or reassure you about efficacy. You can be assured that Psychiatry Drug Alerts is timely and thorough. We screen over 20,000 citations per week. You can also be assured of objectivity because Psychiatry Drug Alerts is independent. There is no sponsorship or advertisers of any kind associated with Psychiatry Drug Alerts. In fact we call special attention to manufacturer-sponsored studies.
You'll find well-written, easy to read updates from a diverse selection of journals. Here's a selection from recent issues. . .
Warfarin/Antidepressant Interactions (sertraline and citalopram appear to be safest) |
Clinical Pharmacology and Therapeutics |
Sertraline and Benzodiazepine Screening (false-positive results) |
Psychiatry 2009 |
Early Antidepressant Response (predictive of sustained remission) |
Psychopharmacology Bulletin |
More on Early Response (lack of improvement in 2 weeks, consider change) |
Journal of Clinical Psychiatry |
Transdermal Estradiol for Postpartum Depression (appears to be a promising and safe option) |
Clinical Obstetrics & Gynecology |
Congenital Heart Defects with SRI Exposure (actual number was small, but statistically significant) |
Birth Defects Research |
